These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32707116)

  • 21. Metabolic health of young adults who were born small for gestational age and treated with growth hormone, after cessation of growth hormone treatment: a 5-year longitudinal study.
    van der Steen M; Smeets CC; Kerkhof GF; Hokken-Koelega AC
    Lancet Diabetes Endocrinol; 2017 Feb; 5(2):106-116. PubMed ID: 28011067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Six-month, prospective, longitudinal, open-label caffeine and dextromethorphan phenotyping study in children with growth hormone deficiency receiving recombinant human growth hormone replacement.
    Kennedy MJ; Davis DA; Smith N; Gaedigk A; Pearce RE; Kearns GL
    Clin Ther; 2008 Sep; 30(9):1687-99. PubMed ID: 18840375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-life GH dosing patterns in children with GHD, TS or born SGA: a report from the NordiNet® International Outcome Study.
    Blankenstein O; Snajderova M; Blair J; Pournara E; Pedersen BT; Petit IO
    Eur J Endocrinol; 2017 Aug; 177(2):145-155. PubMed ID: 28522645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Social medicine aspects of growth hormone treatment of children].
    Kreck C; Bingel S; Heberlein E; Schepping M; Winkler U
    Versicherungsmedizin; 1999 Dec; 51(4):186-93. PubMed ID: 10630093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth Hormone Treatment for Short Stature in the USA, Germany and France: 15 Years of Surveillance in the Genetics and Neuroendocrinology of Short-Stature International Study (GeNeSIS).
    Pfäffle R; Land C; Schönau E; Holterhus PM; Ross JL; Piras de Oliveira C; Child CJ; Benabbad I; Jia N; Jung H; Blum WF
    Horm Res Paediatr; 2018; 90(3):169-180. PubMed ID: 30199857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone.
    Rachmiel M; Rota V; Atenafu E; Daneman D; Hamilton J
    Horm Res; 2007; 68(5):236-43. PubMed ID: 17396034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adult mortality or morbidity is not increased in childhood-onset growth hormone deficient patients who received pediatric GH treatment: an analysis of the Hypopituitary Control and Complications Study (HypoCCS).
    Mo D; Hardin DS; Erfurth EM; Melmed S
    Pituitary; 2014 Oct; 17(5):477-85. PubMed ID: 24122237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of Diabetes Treated in Early Adulthood After Growth Hormone Treatment of Short Stature in Childhood.
    Poidvin A; Weill A; Ecosse E; Coste J; Carel JC
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1291-1298. PubMed ID: 28324032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A rational approach to short stature: focus on use and abuse of growth hormone.
    Krishna J
    Indian J Pediatr; 1997; 64(2):145-52. PubMed ID: 10771830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of recombinant human growth hormone.
    Carel JC; Butler G
    Endocr Dev; 2010; 18():40-54. PubMed ID: 20523016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational Study.
    Child CJ; Quigley CA; Cutler GB; Moore WV; Wintergerst KA; Ross JL; Rosenfeld RG; Blum WF
    Horm Res Paediatr; 2019; 91(4):241-251. PubMed ID: 31185471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Needle-Free and Needle-Based Growth Hormone Therapy in Children: A Pooled Analysis of Three Long-Term Observational Studies.
    Rohrer TR; Ceplis-Kastner S; Jorch N; Müller HL; Pfäffle R; Reinehr T; Richter-Unruh A; Weißenbacher C; Holterhus PM; Ferring Arzneimittel GmbH DSC
    Horm Res Paediatr; 2018; 90(6):393-406. PubMed ID: 30836359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormone replacement therapy in children: The use of growth hormone and IGF-I.
    Pfäffle R
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):339-52. PubMed ID: 26051295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cause-specific long-term mortality in survivors of childhood cancer in Switzerland: A population-based study.
    Schindler M; Spycher BD; Ammann RA; Ansari M; Michel G; Kuehni CE;
    Int J Cancer; 2016 Jul; 139(2):322-33. PubMed ID: 26950898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Randomized Phase 2 Study of Long-Acting TransCon GH vs Daily GH in Childhood GH Deficiency.
    Chatelain P; Malievskiy O; Radziuk K; Senatorova G; Abdou MO; Vlachopapadopoulou E; Skorodok Y; Peterkova V; Leff JA; Beckert M;
    J Clin Endocrinol Metab; 2017 May; 102(5):1673-1682. PubMed ID: 28201598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study.
    Swerdlow AJ; Higgins CD; Adlard P; Preece MA
    Lancet; 2002 Jul; 360(9329):273-7. PubMed ID: 12147369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant growth hormone therapy in children with short stature in Kuwait: a cross-sectional study of use and treatment outcomes.
    Al-Abdulrazzaq D; Al-Taiar A; Hassan K; Al-Basari I
    BMC Endocr Disord; 2015 Dec; 15():76. PubMed ID: 26630987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polyradiculoneuropathy in boy with pituitary dwarfism treated with recombinant growth hormone.
    Sakurai T; Kodama S; Urata R; Komatsu M
    Endocr J; 1996 Oct; 43 Suppl():S127-8. PubMed ID: 9076360
    [No Abstract]   [Full Text] [Related]  

  • 39. Overall and Cause-Specific Mortality in Patients With Type 1 Diabetes Mellitus: A Population-Based Cohort Study in Taiwan From 1998 Through 2014.
    Lu CL; Chang YH; Martini S; Chang MF; Li CY
    J Epidemiol; 2021 Sep; 31(9):503-510. PubMed ID: 32741854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety Outcomes During Pediatric GH Therapy: Final Results From the Prospective GeNeSIS Observational Program.
    Child CJ; Zimmermann AG; Chrousos GP; Cummings E; Deal CL; Hasegawa T; Jia N; Lawrence S; Linglart A; Loche S; Maghnie M; Pérez Sánchez J; Polak M; Predieri B; Richter-Unruh A; Rosenfeld RG; Yeste D; Yorifuji T; Blum WF
    J Clin Endocrinol Metab; 2019 Feb; 104(2):379-389. PubMed ID: 30219920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.